PGNY News and Press, Progyny Inc. From 01/09/23

Anticipates Results to be at the High-End of its Previously Provided Financial Guidance Anticipates Reporting Record Fourth Quarter Operating Cash Flow of Approximately $50 Million NEW YORK, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the ...

Summary Compared to many newly listed public companies in recent years, Progyny is thriving as client count and revenues have grown tremendously. Progyny is the market leader in the fertility benefits arena, with a proven and successful management team. With flexible and unmatched f...

Summary Progyny is the only fertility company to gather and publish data about treatment outcomes, which leads to better clinical results compared to the competition. Progyny's superior solutions enable the company to develop a strong brand awareness as it is demonstrated by the company...

Progyny Inc. ( NASDAQ: PGNY ) dropped 7% after a new short report from Jehoshaphat Research on the fertility company. Jehoshaphat said it's short shares of Progyny ( PGNY ). Progyny ( PGNY ) didn't immediately return Seeking Alpha email request for comment. Pr...

NEW YORK, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that it is raising its financial guidanc...

Summary Shares of Progyny have caught a bid in recent months as investors seek out quality cash earners. The trade looks exhausted, however, and a combination of factors suggest recent downside in the PGNY share price is warranted. Shares looked to be fairly priced at $16.90, ...

NEW YORK, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, today announced that Pete Anevski, Progyny’s Chief Executive Officer, and Mark Livingston, Chief Financial...

Progyny, Inc. (PGNY) Q3 2022 Earnings Conference Call November 03, 2022 04:45 PM ET Company Participants James Hart - VP, IR Peter Anevski - CEO Mark Livingston - CFO Conference Call Participants Anne Samuel - JPMorgan Jailendra Singh - Truist Sec...

Progyny press release ( NASDAQ: PGNY ): Q3 GAAP EPS of $0.13 beats by $0.08 . Revenue of $205.4M (+68.0% Y/Y) beats by $10.96M . Shares +6.6% . FY 2022 Outlook : Revenue is now projected to be $775.0 million to $785.0 million, reflecting growth of 5...

Receives Record Number of New Client Commitments in Selling Season Reports Record Quarterly Revenue of $205.4 Million, Reflecting 68% Growth Over the Prior Year Period Raises Full Year 2022 Guidance, Reflecting Fourth Quarter Revenue Growth of 59% to 67% NEW YORK, Nov. 03, 2022 (GLO...